chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Half her face swollen from all of these vaccines/ It was her left side; her lip and face were a little swollen; flushing/ just right cheek would flush real red; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Lot number: EL1283), in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: SWELLING FACE (non-serious), outcome "recovered", described as "Half her face swollen from all of these vaccines/ It was her left side"; LIP SWELLING (non-serious), outcome "recovered", described as "her lip and face were a little swollen"; FLUSHING (non-serious), outcome "recovered", described as "flushing/ just right cheek would flush real red". Therapeutic measures were taken as a result of swelling face, lip swelling, flushing.  Additional information: Patient stated she is fat as medical history (no height, weight, or BMI reported) for 20-25 years. First COVID-19 vaccine dose was administered either on 21Jan2021 or 20Jan2021, it was a zero with a line going through it. Patient received four doses of Pfizer vaccines. Half her face was swollen from all of these vaccines. It was her left side. She recovered completely. It took a long time for the face to be normal. It was not swollen real big, but her lip and face were a little swollen. The first one she had, the doctor onsite said to take diphenhydramine hydrochloride  (BENADRYL) and she told him she already takes allergy pills. She took diphenhydramine hydrochloride  when she got home. She also had flushing with 3 of them. Just right cheek would flush real red. She had with the first 3; she could have had for the last one. Patient stated she takes her normal medications (not further specified).
Injection site pain and soreness from time of injection to time of event reporting. New onset of localized erythema,  swelling and pruritis to injection site beginning at 2:30pm on date of report. No other associated symptoms.
Developed a black and blue at injection site; aches; chills; fever of 100 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Developed a black and blue at injection site), PAIN (aches), CHILLS (chills) and PYREXIA (fever of 100 degrees Fahrenheit) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 0414A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Developed a black and blue at injection site), PAIN (aches), CHILLS (chills) and PYREXIA (fever of 100 degrees Fahrenheit). At the time of the report, VACCINATION SITE DISCOLOURATION (Developed a black and blue at injection site), PAIN (aches), CHILLS (chills) and PYREXIA (fever of 100 degrees Fahrenheit) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 100 (High) fever of 100 degrees Fahrenheit.         No concomitant medications reported by investigator o No treatment medications provided by the reporter.   Action taken with mRNA-1273 Moderna vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUN-2021: Events outcome was updated to recovered/resolved.
Got sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got sick). At the time of the report, ILLNESS (Got sick) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Red rash over face and neck. Off and on for 3 days. Got better with Benadryl.
general feeling of being unwell; my head and neck to hurt; my head and neck to hurt; This is a spontaneous report from a contactable consumer, reported for herself. A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration, administered in Arm Left on 01Jul2021 12:00 as a single dose for covid-19 immunization. Medical history included hypersensitivity- Sulfamethoxazole drugs, food allergy -Allergies: hazelnuts/Almonds. There were no concomitant medications. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Jul2021 21:30, the patient experienced general feeling of being unwell, my head and neck to hurt. The patient did not receive any treatment. Outcome of the event was not recovered. Device Date was 23Jul2021.
Reports that she felt drained, chills, felt febrile (no temp taken), flushed, lack of appetite, and headache. Reports that hse had started her period that day as well. Right presents with redness & swelling, warm to touch of upper deltoid area swelling radiating to back of arm as well. No streaking noted. Patient has appointment today with MD and is to have arm evaluated. 2/11/2008 Patient called to report that MD felt that it was possibly a reaction to the immunization. Swelling is presently gone and no s/s remain.
Swelling, itchiness, redness at site of injection (L deltoid) 5 - 6 cm reaction - round - slightly erythematous lesion. Slight induration, no fluctuance.
Chronic ideopathic urticaria, daily outbreaks that occur in the evenings.
Pt was administered 0.5ml for his Moderna booster instead of the recommended 0.25ml dose.
Patient scheduled by facility for 1 dose COVID vaccine.*Client give Moderna dose on 07-16-21.*Later review showed that client had received Jansenn vaccine on 06/10/2021.*Inadvertant dose
At approx. 14:30 on 1/18/02, immediately after receiving 2nd Hep-B in the right arm, the client slumped to the floor from her chair. She was conscious, eyes open and her head shook 3 times and she stated "this never happened before". Her BP was checked by the NP immediately and said to be 76/50. I gave her 1/2 bottle glucose tolerance solution to drink. She stated earlier that she had only had a bag of chips to eat and that she usually feels "hot
After vaccine first dose symptoms were mild, I get an IGG every month, but I had slight redness and sore to touch.  The second dose I had a temperature of 101.4 that night and so weak and I thought it was because of the temperature. My stomach was gassy and the next morning I had to go to get my IGG but I was so weak that my husband had to drive me and I felt like I was going to fall. When I got there to get IGG they gave me meds to get my temperature down but I was so weak I couldn't get off the bed or get my jacket on. That night my temp went up to 100.9 and had a low grade fever for the next four days 99-100. Today I still have problems getting out of bed, muscle weakness, cant drive the car, open the car door, have to hold on to banisters, such muscle weakness. I got some test this past Thursday and they think I may have Parkinson's disease and they're not sure if the vaccine caused me to go into Parkinson's.
This spontaneous report as received from a licensed practical nurse refers to a 2 weeks old male patient who on 12-JUL-2012 was accidentally vaccinated with ROTATEQ (lot number reported as 00418E, Exp. Date: 05-APR-2013). No other co-suspects were reported. No concomitant medications were reported. It was reported that the patient was not given the full dose, and only a couple of drops got in his mouth. No adverse events were reported. Follow up information has been received from the licensed practical nurse and refers to a 2 weeks old male patient with no pre-existing allergies, birth defects, medical conditions, adverse events following prior vaccination and no illness at the time of vaccination. On 12-JUL-2012 at 15:45, the patient was accidentally vaccinated with ROTATEQ (lot number reported as 0041AE; previously reported as 00418E; exp. date 05-APR-2013). The doctor walked into a room and noticed that a new float medical assistant had been just starting to give oral ROTATEQ to the child as she thought the child was 2 months old. The doctor realized that the child was only 2 weeks old and stopped her. The child only received 2-3 small drops. The reported that they monitored the child for weeks and the child was fine. No symptoms were reported as all. The nurse reported that there was no adverse events. Additional information is not expected.
swelling & arthritic sx; below MCP's esp 1st & 2nd; also diffuse DIP's/PIP's tenderness lt elbow/shoulder; minor swelling below knees; swelling below plantar feet; swelling below wrist couple of days p/MMR vax;
Immediately after receiving vaccine I felt strange, approximately 2min later I started developing hives and itching. At approx 8:30pm I took 50mg of Benadryl, hives and itching shortly resolved after approx 15min.
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. SORENESS
No tep mild pruritis approx. 40 lesions trunk, lip-several appear that they will crust.
Pt c/o lump size between a walnut and a lemon at site of injection. Achy and painful. Advised pt per Dr. to ice the site, take TYLENOL or ibuprofen and BENADRYL as needed. Pt to call office if any new or persisting sx occur.
5 min after shot had flushing, tachycardia and numb lips. 4 days later I developed tachycardia, chest pain, dyspnea, body aches
No additional AEs reported; The patient was intended to be administered MMR II however PROQUAD was accidently administered; This spontaneous report was received from a nurse concerning a 15-months-old patient of unknown gender. Information regarding the patient's concomitant therapies, current conditions and medical history was not provided.   On 03-DEC-2021, the patient received varicella zoster vaccine live (OKA/MERCK) (VARIVAX).  On 28-JAN-2022, the patient was inadvertently vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 0.5 milliliter lot number T028137 (rHA) and expiration date 15-FEB-2022 (route of administration was not provided) as prophylaxis, instead of receiving Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (Extra dose administered).  No additional adverse events were reported.
Information has been received from a registered nurse through the Merck pregnancy registry concerning a 21 year old hispanic female patient with a history of cervical dysplasia and headaches with no allergies who on 23-Mar-2007, was vaccinated with a first dose of Gardasil (Lot #656049/0187U).  Concomitant therapy included acetaminophen as needed.  The nurse reported that the patient had a blood pregnancy test on 02-Apr-2007 and was confirmed to be pregnant.  Her last menstrual period was 24-Feb-2007 and her estimated due date was 01-Dec-2007.  It was reported that her pregnancy was normal to date.  On 11-May-2007, cetirizine hydrochloride (Zyrtec) 10 mg as needed was prescribed for nausea.  On 05-Jul-2007, the patient had an ultrasound for a fetal survey.  The results of the test were within normal limits; fetal growth was appropriate.  On 30-Aug-2007, iron (unspecified) 65mg daily, was prescribed for anemia.  On 02-Nov-2007, a second ultrasound was performed for a fetal survey and the result of this test was low amniotic fluid or oligohydramnios.  On 12-Nov-2007, a biophysical profile test was performed.  On 25-Nov-2007, the patient delivered a female baby weighing 6 pounds 6 ounces and measuring 19 inches in length.  The patient was reported to be 39 weeks from her last menstrual period.  The infant was reported to be normal with no congenital anomalies or other complications.  At the time of this report, the patient's outcome was unknown.  Additional  information is not expected.
Soreness on Both arms, unusual acute pain of hands and fingers  at joints and left wrist
Information has been received from a consumer who stated that he or she knew someone that died soon after receiving the MMR II. Attempts to verify the existence of an identifiable patient and reporter have been unsuccessful. No further information is available.
Patient got dizzy, numbness through body, blurry vision, passed out from a standing position, hit head, had mild seizure like symptoms, unconscious for 30 seconds, hard to come to, extreme pain in arm and neck for hours following. Vomited about 90 mins later. She was given ibuprofen shortly after incident, then other various treatments at home.
PATIENT WAS GIVEN DOSE TOO EARLY, PATIENT NOTIFIED, NO FURTHER ACTION REQUIRED. LAST DOSE WAS 5/18/21.
Adult dose 1ml instead of the peds dose of 0.5 ml  -no adverse effects noted from the adult dose given mom has not  reported any adverse effects.  Call has been p[laced to om x2 to check on patient.  Message left mom has not returned  my call.
Headache, chills and chest tightness. Beginning 8 hours after injection of second dose in series. Patient presented to emergency department two days later with persistent chest tightness and abnormal breathing sensation.  ECG consistent with acute pericarditis.
Admitted to hospital for altered mental status. Two days later patient became apneic and responsive only to pain requiring intubation.  At the time bilateral upper extremities were observed to have spastic movements.  Patient then was transferred to critical care unit.  Patient was finally extubated on 12/10 and transferred out of unit on 12/11/21.
Petechiae or extremities/ arms/legs- also ecchymosis at site of vaccination.  5/15/2008 MR received for DOS 4/04-07/2008 with DX: ITP. Pt presented bruising which started at injection sites of vaccines.  Petechiae noted on lower extremities,  chest, back, and eyelids.  Tx with IVIG and WinRho.  Pt developed h/a, neck stiffness. Clinical S&S of aseptic meningitis-likely 2' to IVIG.
Two days red, 3rd day itchy, hard and hot, red size of tennis ball, no fever.
shingles rash; soreness; swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient had any allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG6199) via an unspecified route of administration in the left arm on 24Mar2021 at 12:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 12:00, the patient got shingles. Started with soreness and swollen lymph nodes and then shingles rash. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatments for the events. The clinical outcome of the events soreness, swollen lymph nodes and shingles rash was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Very intense localized rash developed at injection site. Lasted about 5 days and was itchy / hot too touch.
I woke up with a 6/10 headache, myalgias, arthralgias, chills, and a low grade fever 100.2.  By the next day my fever rose to 102.3.  My muscles and joints hurt so much that I had trouble carrying my 11 pound son and I had trouble walking up and down the stairs.  My symptoms began to improve after 48 hours and by the morning of 11/22/09 they resolved completely.
ORIGINALLY HAD PNEUMOVAX IN 2006, PREVNAR 13 IN 2016 WITHOUT INCIDENT. PATIENT HAD PNEUMOVAX ON 7/7/17 AND LATER THAT EVENING NOTED LEFT MEDIAL ARM  SWELLING, TENDERNESS, AND REDNESS. SEEN FOR EVALUATION IN DR'S OFFICE ON 7/10/17.
Started showing signs of hives, ichy rash all over body (legs, arms, buttocks, face, shoulders, and back) approx 15-20 minutes after administration of flu doseage. Returned to the doctors immediately and was told to administer 1 tsp of Children's Bendryl every 4-6 hours until symtoms were relieved.
Client complained of sore arm and unable to lift arm. Applied ice packs and was instructed to see a physician if not better. Had no swelling or redness.
I am pregnant; I got vaccinated back in February; I just got COVID; I am tested positive; I got vaccinated back in February; I just got COVID; I am tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 34 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 (Lot number: EL3247) at the age of 33 years as dose 2, single and administered in arm left, administration date 01Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FERROUS SULFATE; IRON; PRENATAL [FOLIC ACID;IRON]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 28Dec2021, outcome "unknown" and all described as "I got vaccinated back in February; I just got COVID; I am tested positive"; MATERNAL EXPOSURE DURING PREGNANCY (non-serious), outcome "unknown", described as "I am pregnant". The patient underwent the following laboratory tests and procedures: blood test: (unspecified date) unknown results; sars-cov-2 test: (28Dec2021) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. with Tylenol. Patient takes one pill 500 milligrams. Patient took 3 pills in the past two days and that was it.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a consumer refers to a 78 years old female patient with skin cancer, penicillin allergy and "blue dye" allergy. The patient was vaccinated with ZOSTAVAX subcutaneous injection on 25-OCT-2012. No other co-suspects were reported. Concomitant medications included digoxin, LOSARTAN and tizanidine. Three days after the vaccination the patient experienced arm and shoulder pain. She was also experiencing severe leg cramps, and "recently"itching in her legs and burning in her legs. Her blood pressure also became elevated to 161/100. On 16-NOV-2012 the patient went to see her physician and she was diagnosed with shingles. Treatment medication included VALTREX and MEXICAM. The patient also visited her cardiologist due to the elevated blood pressure. No outcome was reported and no causality assessment was provided. Additional information has been requested.
2 small pustules around vaccination site; 2 pustules with surrounding erythema by axilla; 4cm induration on left chest above left nipple, with overlying erythema. Treated with pulse-dose prednisone, keflex, motrin.
¨i am sick , i Was Diagnosed with COVID¨; ¨i am sick , i Was Diagnosed with COVID¨; Lack of efficacy; Delayed reaction; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (¨i am sick , i Was Diagnosed with COVID¨), COVID-19 (¨i am sick , i Was Diagnosed with COVID¨), TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction) and DRUG INEFFECTIVE (Lack of efficacy) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 037U20A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction). On 10-May-2021, the patient experienced ILLNESS (¨i am sick , i Was Diagnosed with COVID¨), COVID-19 (¨i am sick , i Was Diagnosed with COVID¨) and DRUG INEFFECTIVE (Lack of efficacy). On 10-May-2021, DRUG INEFFECTIVE (Lack of efficacy) outcome was unknown. At the time of the report, ILLNESS (¨i am sick , i Was Diagnosed with COVID¨), COVID-19 (¨i am sick , i Was Diagnosed with COVID¨) and TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided. Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.  The event of drug ineffective is assessed as possible. Based on the current available information and temporal association between the use of the product and the start date of the event of Type IV hypersensitivity reaction, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Upon internal review on 14 Jul 2021, an event (lack of efficacy) was added at Moderna's request.; Sender's Comments: Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.  The event of drug ineffective is assessed as possible. Based on the current available information and temporal association between the use of the product and the start date of the event of Type IV hypersensitivity reaction, a causal relationship cannot be excluded.
Pt could not move arm for week after injection given. Went to ER and pt stated ER physician said injection given to high and might of hit tendons/nerve.
Rash and hard bump distally by 4 inches to injection site that last about 48 hours.
It started with fever, fatigue. The fever went up to 102 and I got it from my son. The fever last about 4 days. I had a little cough and chest discomfort, a lot of phlegm in morning. I had a headache, muscle pain and extreme fatigue. I still have fatigue, I sweat more than I use to.